Key Insights

Highlights

Treatment Research

6 treatments under study, led by Minoxidil

Research Leaders

7 sponsors active, led by Bioskin GmbH

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Phase 3 (2)
Phase 4 (1)

Trial Status

Active Not Recruiting2
Withdrawn1
Not Yet Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT05888922Phase 3Active Not Recruiting

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

NCT07817277Not Yet Recruiting

Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination

NCT07146022Phase 3Active Not Recruiting

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

NCT02483195Phase 4WithdrawnPrimary

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Showing all 4 trials

Research Network

Common Treatments

  • Minoxidil2
  • Finasteride1
  • Vdphl01 Qd1
  • Vdphl01 Bid1
  • Vehicle Solution1

Active Sponsors

  • Bioskin GmbH1
  • Industrial Farmacéutica Cantabria, S.A.1
  • Industrial Farmaceutica Cantabria S.A.1
  • University of Florida1
  • Veradermics, Inc.1

Top Investigators

Related Conditions

  • Androgenetic Alopecia2
  • Diabete Mellitus1
  • Androgenetic Alopecia Aga1
  • Female Pattern Baldness1
  • Dermoscopy1

Activity Timeline